Investors & Media International Stem Cell Corporation CEO Issues Statement on De-Differentiation Research and Parthenogenesis International Stem Cell Names Noted Reproductive Endocrinologist to Scientific Advisory Board International Stem Cell Corporation Creates Human Cornea Tissue from Its Parthenote Stem Cells; Preliminary Discovery Holds Promise to Aid in Therapy for Blindness International Stem Cell Corporation Opens European Distribution Channel, Signs Contract with CellSystems Biotechnologie Vertrieb International Stem Cell Corporation Contracts to Manufacture Adipose-Derived Stem Cells for Cytori Therapeutics International Stem Cell Corporation to Present at Roth Capital Partners New York Institutional Investor Conference September 5, 2007 International Stem Cell Corporation Issues Letter to Shareholders International Stem Cell Corporation Names Edward O. Hunter, Paul V. Maier, to Board of Directors Peer Review Paper Reporting Creation of Human Stem Cell Lines That Can Become Any Cell Type Using Unfertilized Eggs, Co-Authored by Scientists at International Stem Cell Corporation/Lifeline Cell Technology Neuronascent, Inc. Announces License of Its Patented Animal Cells to Lifeline Cell Technology, LLC 28 29 30 31 32 33 34 35 << < > >>
